These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32504333)

  • 21. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: A systematic review and meta-analysis.
    Emile SH; Elfeki H; Shalaby M; Sakr A; Kim NK
    Surgery; 2021 May; 169(5):1005-1015. PubMed ID: 33317903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study.
    Watanabe J; Ohya H; Sakai J; Suwa Y; Goto K; Nakagawa K; Ozawa M; Ishibe A; Suwa H; Kunisaki C; Endo I
    Tech Coloproctol; 2023 Sep; 27(9):759-767. PubMed ID: 36773172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
    Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of laparoscopic lateral pelvic lymph node dissection on urinary retention in rectal cancer.
    Sadakari Y; Hisano K; Sada M; Mizuuchi Y; Nagayoshi K; Fujita H; Nagai S; Manabe T; Ueki T; Nakamura M
    Surg Endosc; 2022 Feb; 36(2):999-1007. PubMed ID: 33616731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lateral lymph node dissection reduces local recurrence of locally advanced lower rectal cancer in the absence of preoperative neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.
    Gao X; Wang C; Yu Y; Singh D; Yang L; Zhou Z
    World J Surg Oncol; 2020 Nov; 18(1):304. PubMed ID: 33228677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
    Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
    BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?
    Yang X; Gu C; Hu T; Bi L; Wei M; Deng X; Wang Z; Zhou Z
    ANZ J Surg; 2019 Nov; 89(11):E492-E497. PubMed ID: 31566296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.
    Atef Y; Koedam TW; van Oostendorp SE; Bonjer HJ; Wijsmuller AR; Tuynman JB
    World J Surg; 2019 Dec; 43(12):3198-3206. PubMed ID: 31468119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
    Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
    Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lateral pelvic lymph node metastasis in T2 low rectal cancer: is TME alone sufficient for cure?
    Ouchi A; Inoue M; Sato Y; Takamizawa Y; Kinoshita T; Moritani K; Komori K; Tsukamoto S; Shimizu Y; Kanemitsu Y
    Jpn J Clin Oncol; 2023 Apr; 53(5):386-392. PubMed ID: 36722355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic and robotic lateral lymph node dissection for rectal cancer.
    Nakanishi R; Yamaguchi T; Akiyoshi T; Nagasaki T; Nagayama S; Mukai T; Ueno M; Fukunaga Y; Konishi T
    Surg Today; 2020 Mar; 50(3):209-216. PubMed ID: 31989237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
    Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
    J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pay attention to the selective lateral pelvic lymph node dissection in mid-low rectal cancer].
    Meng W; Wang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):258-262. PubMed ID: 28338156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lateral lymph node dissection in advanced low rectal cancer treatment.
    Li J; Shiomi A
    Int J Colorectal Dis; 2021 Nov; 36(11):2361-2371. PubMed ID: 34152455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.